Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT)
- PMID: 33809275
- PMCID: PMC8005945
- DOI: 10.3390/tropicalmed6010034
Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT)
Erratum in
-
Correction: Nalin, D. Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT). Trop. Med. Infect. Dis. 2021, 6, 34.Trop Med Infect Dis. 2022 Jun 14;7(6):103. doi: 10.3390/tropicalmed7060103. Trop Med Infect Dis. 2022. PMID: 35736991 Free PMC article.
Abstract
The original studies demonstrating the efficacy of oral glucose-electrolytes solutions in reducing or eliminating the need for intravenous therapy to correct dehydration caused by acute watery diarrheas (AWD) were focused chiefly on cholera patients. Later research adapted the oral therapy (ORT) methodology for treatment of non-cholera AWDs including for pediatric patients. These adaptations included the 2:1 regimen using 2 parts of the original WHO oral rehydration solution (ORS) formulation followed by 1 part additional plain water, and a "low sodium" packet formulation with similar average electrolyte and glucose concentrations when dissolved in the recommended volume of water. The programmatic desire for a single ORS packet formulation has led to controversy over use of the "low sodium" formulations to treat cholera patients. This is the subject of the current review, with the conclusion that use of the low-sodium ORS to treat cholera patients leads to negative sodium balance, leading to hyponatremia and, in severe cases, particularly in pediatric cholera, to seizures and other complications of sodium depletion. Therefore it is recommended that two separate ORS packet formulations be used, one for cholera therapy and the other for non-cholera pediatric AWD.
Keywords: ORS formulations; cholera; hyponatremia; hyponatremic seizures; hyponatremic sequelae; non-cholera acute watery diarrheas (AWDs); oral rehydration solutions (ORS); sodium balance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- WHO Reduced Osmolarity Oral Rehydration Salts (ORS) Formulation; Department of Child and Adolescent Health and Development. [(accessed on 20 October 2020)]. Available online: https://apps.who.int/iris/handle/10665/67322.
-
- Alam S., Afzal K., Maheshwari M., Shukla I. Controlled trial of hypo-osmolar versus world Health Organization Oral rehydration solution. Indian Pediatrics. 2000;37:952–960. - PubMed
-
- Pulungsih S.P., Punjabi N.H., Rafli K., Rifajati A., Kumala S., Simanjuntak C.H., Yuwono Lesmana M., Subekti D., Sutoto, Fontaine O. Standard WHO_ORS versus reduced-osmolarity ORS in the management of cholera patients. J. Health Popul. Nutr. 2006;24:107–112. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
